Cypress Bioscience Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
20.68 Mil |
| Income |
-30.48 Mil |
| Net Profit Margin |
-147.39% |
| Return on Equity |
-19.77% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
0.54 |
| Earnings/Share |
-0.80 |
| Book Value/Share |
3.75 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 7.9 | 14.2 | 1.0 |
| 2nd Qtr | 5.8 | 1.0 | 5.9 |
| 3rd Qtr | 6.1 | 1.0 | 1.0 |
| 4th Qtr | NA | 0.9 | 6.1 |
| Total | 19.7 | 17.2 | 13.9 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.24 | -$0.08 | -$0.04 |
| 2nd Qtr | -$0.23 | -$0.11 | $0.07 |
| 3rd Qtr | -$0.14 | -$0.11 | -$0.02 |
| 4th Qtr | NA | -$0.19 | $0.08 |
| Total | -$0.61 | -$0.49 | $0.09 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -26% | NA | --- |
| 2nd Qtr | 4% | -38% | NA |
| 3rd Qtr | 39% | 0% | NA |
| 4th Qtr | NA | -73% | NA |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -200% | -100% |
| 2nd Qtr | -109% | NA |
| 3rd Qtr | -27% | -450% |
| 4th Qtr | NA | NA |
advertisement
Recent News